Dubai - The NCEMA reports 'positive results' from Phase III clinical trials.
The UAE's National Emergency, Crisis and Disaster Management Authority (NCEMA) has reported that the Chinese Sinopharm vaccine shows 100 per cent protection against moderate and severe Covid-19 infections.
In a tweet, it said the vaccine achieved positive results, with the efficacy rate reaching 86 per cent.
This follows Phase III clinical trials of both the Sinopharm and Russia's Sputnik V vaccine, it was revealed at Tuesday's Covid-19 briefing held by the UAE Government.
The NCEMA added that the 'Hope Consortium' launched by the UAE in November is prepared to facilitate and support the distribution of 6 billion doses of vaccinations around the world, with the aim of increasing this capacity to 18 billion by the end of 2021.
Also read: UAE vaccine for coronavirus: Sinopharm's jab approved
UAE among 10 best countries for Covid-19 treatment
UAE a major hub in global Covid-19 fight, 80% supplies pass through Dubai
Meanwhile, Dubai is planning to inoculate 70% of its population with the Covid-19 vaccine produced by Pfizer and BioNTech by the end of 2021, in a campaign free of charge for citizens and residents, a health official said on Tuesday.
The ramping up of the vaccination drive comes after the UAE has detected a “limited number” of cases of the new strain of Covid-19, a top official has said. The affected individuals had come from abroad.